Literature DB >> 10749620

Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients.

L Gamrin1, P Essén, E Hultman, M A McNurlan, P J Garlick, J Wernerman.   

Abstract

OBJECTIVE: To investigate the effect of growth hormone (GH) treatment on skeletal muscle protein catabolism in patients with multiple organ failure in the intensive care unit (ICU). SUMMARY BACKGROUND DATA: Skeletal muscle depletion affects the incidence of complications and the length of hospital stay. A protein-sparing effect of GH treatment in skeletal muscle of long-term ICU patients was hypothesized.
METHODS: Twenty critically ill ICU patients were randomized to treatment with GH (0.3 U/kg/day) or as controls. Percutaneous muscle biopsy samples were taken before and after a 5-day treatment period starting on day 3 to 42 of the patient's ICU stay. Protein content, protein synthesis, water, nucleic acids, and free amino acids in muscle were analyzed.
RESULTS: The protein content decreased by 8% +/- 11% in the control patients, with no significant change in the GH group. The fractional synthesis rate of muscle proteins increased in the GH group by 33% +/- 48%, and muscle free glutamine increased by 207% +/- 327% in the GH group. Total intramuscular water increased by 12% +/- 14% in the control group as a result of an increase in extracellular water of 67% +/- 86%; these increases were not seen in the GH group. In contrast, the intracellular water increased by 6% +/- 8% in the GH group.
CONCLUSION: Treatment with GH for 5 days in patients with multiple organ failure stimulated muscle protein synthesis, increased muscle free glutamine, and increased intracellular muscle water.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749620      PMCID: PMC1421035          DOI: 10.1097/00000658-200004000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  35 in total

1.  Muscle composition in relation to age and sex.

Authors:  A M Forsberg; E Nilsson; J Werneman; J Bergström; E Hultman
Journal:  Clin Sci (Lond)       Date:  1991-08       Impact factor: 6.124

2.  Growth hormone attenuates the abnormal distribution of body water in critically ill surgical patients.

Authors:  C Gatzen; M R Scheltinga; T D Kimbrough; D O Jacobs; D W Wilmore
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

3.  Long term survival after intensive care.

Authors:  S Ridley; R Jackson; J Findlay; P Wallace
Journal:  BMJ       Date:  1990-11-17

4.  Nitrogen retention caused by growth hormone in patients undergoing gastrointestinal surgery with epidural analgesia and parenteral nutrition.

Authors:  M Mjaaland; K Unneberg; R Hotvedt; A Revhaug
Journal:  Eur J Surg       Date:  1991-01

5.  Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition.

Authors:  M Mjaaland; K Unneberg; J Larsson; L Nilsson; A Revhaug
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

6.  Measurement of protein synthesis in human skeletal muscle: further investigation of the flooding technique.

Authors:  M A McNurlan; P Essen; S D Heys; V Buchan; P J Garlick; J Wernerman
Journal:  Clin Sci (Lond)       Date:  1991-10       Impact factor: 6.124

7.  Muscle intracellular electrolytes in patients with chronic uremia.

Authors:  J Bergström; A Alvestrand; P Fürst; E Hultman; U Widstam-Attorps
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

8.  Temporal responses of protein synthesis in human skeletal muscle to feeding.

Authors:  M A McNurlan; P Essen; E Milne; E Vinnars; P J Garlick; J Wernerman
Journal:  Br J Nutr       Date:  1993-01       Impact factor: 3.718

9.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

Authors:  R Ross; J Miell; E Freeman; J Jones; D Matthews; M Preece; C Buchanan
Journal:  Clin Endocrinol (Oxf)       Date:  1991-07       Impact factor: 3.478

10.  Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole-body nitrogen economy after operation.

Authors:  F Hammarqvist; C Strömberg; A von der Decken; E Vinnars; J Wernerman
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

View more
  15 in total

Review 1.  Nutritional papers in ICU patients: what lies between the lines?

Authors:  Jean-Charles Preiser; René Chioléro; Jan Wernerman
Journal:  Intensive Care Med       Date:  2002-12-21       Impact factor: 17.440

2.  Sparing of muscle mass and function by passive loading in an experimental intensive care unit model.

Authors:  Guillaume Renaud; Monica Llano-Diez; Barbara Ravara; Luisa Gorza; Han-Zhong Feng; Jian-Ping Jin; Nicola Cacciani; Ann-Marie Gustafson; Julien Ochala; Rebeca Corpeno; Meishan Li; Yvette Hedström; G Charles Ford; K Sreekumaran Nair; Lars Larsson
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

3.  Inhibition of jejunal protein synthesis and breakdown in Pseudomonas aeruginosa-induced sepsis pig model.

Authors:  Gabriëlla A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-04-12       Impact factor: 4.052

4.  Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms.

Authors:  Julien Ochala; Ann-Marie Gustafson; Monica Llano Diez; Guillaume Renaud; Meishan Li; Sudhakar Aare; Rizwan Qaisar; Varuna C Banduseela; Yvette Hedström; Xiaorui Tang; Barry Dworkin; G Charles Ford; K Sreekumaran Nair; Sue Perera; Mathias Gautel; Lars Larsson
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

5.  Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients.

Authors:  Inga Tjäder; Olav Rooyackers; Ann-Marie Forsberg; Rokhsareh F Vesali; Peter J Garlick; Jan Wernerman
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

6.  Enhancement of muscle mitochondrial function by growth hormone.

Authors:  Kevin R Short; Niels Moller; Maureen L Bigelow; Jill Coenen-Schimke; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

7.  Beta-blockade and growth hormone after burn.

Authors:  David W Hart; Steven E Wolf; David L Chinkes; Sofia O Lal; Peter I Ramzy; David N Herndon
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

8.  Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.

Authors:  Zhao-Feng Tang; Yun-Biao Ling; Nan Lin; Zheng Hao; Rui-Yun Xu
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

Review 9.  Interventions for preventing critical illness polyneuropathy and critical illness myopathy.

Authors:  Greet Hermans; Bernard De Jonghe; Frans Bruyninckx; Greet Van den Berghe
Journal:  Cochrane Database Syst Rev       Date:  2014-01-30

10.  Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial.

Authors:  Selina M Parry; Sue Berney; René Koopman; Adam Bryant; Doa El-Ansary; Zudin Puthucheary; Nicholas Hart; Stephen Warrillow; Linda Denehy
Journal:  BMJ Open       Date:  2012-09-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.